Pricing Log in Create free account
Friday 6 November 2026 Export BRKR’s income statement to Excel — free account

Bruker Corporation

BRKR Healthcare Medical Devices

Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.

Revenue
+1.57%
EPS
−75.4%
Free cash flow
+278.7%
Total debt
−14.7%

Quarter to September 2026, against a year earlier

61.17 3.11 +5.36%
Market cap
$8.9B
P/E
0.0×
Fwd P/E
−412×
Dividend yield
0.34%
F-score
4/9
Altman Z
2.43
Beneish M
−2.56
Dividend safety
34/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Bruker Corporation (BRKR) SEC filings, changes and red flags

Red flags

  • Impairment

    Bruker Corporation recorded a goodwill impairment of $174.5 million in fiscal Q3 2026

    10-Q filed · The filing · sec.gov

  • Officer departure

    Bruker Corporation reported the departure of an officer or director

    8-K filed · The filing · sec.gov

Filings

Form Period Filed What it reports Flags
8-K Nov 5, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 30, 2026 P1I2: 18 added · 12 removed · 31 modified
P2I1A: no changes 		Impairment
8-K Nov 4, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 29, 2026 8.01 Other events
8-K Aug 14, 2026 8.01 Other events
10-Q Jun 30, 2026 P1I2: 26 added · 13 removed · 31 modified
P2I1A: 1 modified
8-K Aug 4, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 30, 2026 8.01 Other events
8-K/A May 21, 2026 5.07 Submission of matters to a vote of security holders
8-K May 21, 2026 5.07 Submission of matters to a vote of security holders
8-K May 15, 2026 8.01 Other events
10-Q Mar 31, 2026
8-K May 6, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 28, 2026 8.01 Other events
8-K Apr 10, 2026 5.02 Departure or appointment of directors or officers Officer departure
8-K Apr 1, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 10 added · 57 removed · 79 modified
1A: 36 added · 13 removed · 71 modified
7: 25 added · 23 removed · 31 modified
8-K Feb 20, 2026 5.02 Departure or appointment of directors or officers; 8.01 Other events
8-K Feb 12, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 12, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure
8-K Dec 9, 2025 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Nov 3, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 3, 2025 3.03 Material modification of shareholders' rights; 5.03 Amendments to the articles or bylaws; change in fiscal year; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
8-K Aug 4, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 21, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K May 7, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 11, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Feb 13, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 13, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure
10-Q Sep 30, 2024
8-K Nov 5, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 6, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 2, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 13, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 8, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.